Elevated endocan levels have been proposed not only as a biomarker but also as a mediator of endothelial dysfunction, via its regulation of ICAM-1/VCAM-1 expression and oxidative stress pathways. The gene discussed is VCAM1; the disease is endothelial dysfunction.